Cargando…

DNA-based artificial dendritic cells for in situ cytotoxic T cell stimulation and immunotherapy

In immunotherapy, ex vivo stimulation of T cells requires significant resources and effort. Here, we report artificial dendritic cell-mimicking DNA microflowers (DM) for programming T cell stimulation in situ. To mimic dendritic cells, DNA-based artificial dendritic microflowers were constructed, su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le, Quoc-Viet, Lee, Jaiwoo, Byun, Junho, Shim, Gayong, Oh, Yu-Kyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	KeAi Publishing 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940766/ https://www.ncbi.nlm.nih.gov/pubmed/35386353 http://dx.doi.org/10.1016/j.bioactmat.2021.12.001

Ejemplares similares

Cell membrane-derived vesicles for delivery of therapeutic agents
por: Le, Quoc-Viet, et al.
Publicado: (2021)

Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis
por: Lee, Jaiwoo, et al.
Publicado: (2022)

Enzyme‐responsive macrocyclic metal complexes for biomedical imaging
por: Le, Quoc‐Viet, et al.
Publicado: (2022)

High Molecular Weight Chitosan-Complexed RNA Nanoadjuvant for Effective Cancer Immunotherapy
por: Choi, Jin Joo, et al.
Publicado: (2019)

Photosensitizer-Trapped Gold Nanocluster for Dual Light-Responsive Phototherapy
por: Byun, Junho, et al.
Publicado: (2020)

Molecular engineering of antibodies for site-specific conjugation to lipid polydopamine hybrid nanoparticles
por: Yang, Hobin, et al.
Publicado: (2020)

In vivo fate and intracellular trafficking of vaccine delivery systems()
por: Lee, Jaiwoo, et al.
Publicado: (2022)

Nanomaterials for modulating innate immune cells in cancer immunotherapy
por: Le, Quoc-Viet, et al.
Publicado: (2019)

Targeting dendritic cells in situ for breast cancer immunotherapy
por: Wang, Bei
Publicado: (2012)

In Situ Dendritic Cell Recruitment and T Cell Activation for Cancer Immunotherapy
por: Han, Joonsu, et al.
Publicado: (2022)

Cancer immunotherapy using artificial adjuvant vector cells to deliver NY‐ESO‐1 antigen to dendritic cells in situ
por: Fujii, Shin‐ichiro, et al.
Publicado: (2022)

Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
por: Cheng, Shanshan, et al.
Publicado: (2020)

Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy
por: Calmeiro, João, et al.
Publicado: (2019)

Lipid Nanoparticle-Mediated Lymphatic Delivery of Immunostimulatory Nucleic Acids
por: Kim, Dongyoon, et al.
Publicado: (2021)

Optimizing tumor-associated antigen-stimulated autologous dendritic cell and cytokine-induced killer cell coculture to enhance cytotoxicity for cancer immunotherapy in manufacturing
por: Lee, Yi-Yen, et al.
Publicado: (2023)

SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma
por: Chen, Xuemei, et al.
Publicado: (2018)

Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro
Publicado: (1989)

Dendritic Cells and Their Role in Immunotherapy
por: Gardner, Alycia, et al.
Publicado: (2020)

Dendritic cell immunotherapy: clinical outcomes
por: Apostolopoulos, Vasso, et al.
Publicado: (2014)

Tolerogenic dendritic cell-based immunotherapy
por: Chang, Kiyuk, et al.
Publicado: (2017)

Plasmacytoid Dendritic Cells and Cancer Immunotherapy
por: Fu, Chunmei, et al.
Publicado: (2022)

Nanostructured lipid carrier delivering chlorins e6 as in situ dendritic cell vaccine for immunotherapy of gastric cancer
por: Mao, Mao, et al.
Publicado: (2020)

Therapeutic gene editing: delivery and regulatory perspectives
por: Shim, Gayong, et al.
Publicado: (2017)

Lipid-based nanoparticles for photosensitive drug delivery systems
por: Shim, Gayong, et al.
Publicado: (2022)

A simple in vitro method for evaluating dendritic cell-based vaccinations
por: Pham, Phuc Van, et al.
Publicado: (2014)

Dendritic Cell-Based Immunotherapy for Prostate Cancer
por: Jähnisch, Hanka, et al.
Publicado: (2010)

Dendritic Cell-Based Immunotherapy for Myeloid Leukemias
por: Schürch, Christian M., et al.
Publicado: (2013)

Dendritic cell-based immunotherapy in ovarian cancer
por: Coosemans, An, et al.
Publicado: (2013)

Regulatory Dendritic Cells for Immunotherapy in Immunologic Diseases
por: Gordon, John R., et al.
Publicado: (2014)

Dendritic Cell-Based Immunotherapy for Solid Tumors()()
por: Jung, Nam-Chul, et al.
Publicado: (2018)

Manufacturing Dendritic Cells for Immunotherapy: Monocyte Enrichment
por: Hopewell, Emily L., et al.
Publicado: (2020)

Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy
por: Peng, Xin, et al.
Publicado: (2021)

Dendritic Cell-Based Immunotherapy in Lung Cancer
por: Stevens, Dieter, et al.
Publicado: (2021)

Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
por: Nava, Sara, et al.
Publicado: (2021)

Dendritic Cell-Derived Exosomes in Cancer Immunotherapy
por: Luo, Shumin, et al.
Publicado: (2023)

Immunotherapy of patient with hepatocellular carcinoma using cytotoxic T lymphocytes ex vivo activated with tumor antigen-pulsed dendritic cells
por: Wang, Ying, et al.
Publicado: (2018)

Dendritic Cell-Based Immunotherapies and their Potential use in Colorectal Cancer Immunotherapy
por: Aldahlawi, Alia M., et al.
Publicado: (2021)

Multi-functional cytotoxic T cell expansion correlates with overall survival after administration of autologous dendritic cell immunotherapy in renal cell cancer patients
por: DeBenedette, M, et al.
Publicado: (2013)

HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells
por: Van den Bergh, Johan M J, et al.
Publicado: (2014)

Infection-Mimicking Materials to Program Dendritic Cells In Situ
por: Ali, Omar A., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_5a8ncsfl581hc86830lfg31njv